These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7579750)

  • 1. Basal ganglia and frontal lobe glucose metabolism. A reproducibility positron emission tomography study.
    Goldman S; Dethy S; Lotstra F; Biver F; Stanus E; Wikler D; Hildebrand J; Mendlewicz J; Luxen A
    J Neuroimaging; 1995 Oct; 5(4):219-26. PubMed ID: 7579750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.
    Roelcke U; Kappos L; Lechner-Scott J; Brunnschweiler H; Huber S; Ammann W; Plohmann A; Dellas S; Maguire RP; Missimer J; Radü EW; Steck A; Leenders KL
    Neurology; 1997 Jun; 48(6):1566-71. PubMed ID: 9191767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness.
    Buchsbaum MS; Wu J; DeLisi LE; Holcomb H; Kessler R; Johnson J; King AC; Hazlett E; Langston K; Post RM
    J Affect Disord; 1986; 10(2):137-52. PubMed ID: 2941470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study.
    Farkas T; Wolf AP; Jaeger J; Brodie JD; Christman DR; Fowler JS
    Arch Gen Psychiatry; 1984 Mar; 41(3):293-300. PubMed ID: 6608333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography in degenerative disorders of the dopaminergic system.
    Karbe H; Holthoff V; Huber M; Herholz K; Wienhard K; Wagner R; Heiss WD
    J Neural Transm Park Dis Dement Sect; 1992; 4(2):121-30. PubMed ID: 1571076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Angrist B; Hitzemann R; Lieberman J; Pappas N
    Am J Psychiatry; 1997 Jan; 154(1):50-5. PubMed ID: 8988958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography demonstrates frontal cortex and basal ganglia hypometabolism in dystonia.
    Karbe H; Holthoff VA; Rudolf J; Herholz K; Heiss WD
    Neurology; 1992 Aug; 42(8):1540-4. PubMed ID: 1641150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography in myotonic dystrophy.
    Mielke R; Herholz K; Fink G; Ritter D; Heiss WD
    Psychiatry Res; 1993 Jun; 50(2):93-9. PubMed ID: 8378492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interregional correlations of glucose metabolism between the basal ganglia and different cortical areas: an ultra-high resolution PET/MRI fusion study using 18F-FDG.
    Kim JH; Son YD; Kim JM; Kim HK; Kim YB; Lee C; Oh CH
    Braz J Med Biol Res; 2017 Nov; 51(1):e6724. PubMed ID: 29160415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in brain glucose metabolism in cocaine dependence and withdrawal.
    Volkow ND; Fowler JS; Wolf AP; Hitzemann R; Dewey S; Bendriem B; Alpert R; Hoff A
    Am J Psychiatry; 1991 May; 148(5):621-6. PubMed ID: 2018164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.
    Karbe H; Grond M; Huber M; Herholz K; Kessler J; Heiss WD
    J Neurol; 1992 Feb; 239(2):98-102. PubMed ID: 1552311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered frontostriatal relationship in unmedicated schizophrenic patients.
    Biver F; Goldman S; Luxen A; Delvenne V; De Maertelaer V; De La Fuente J; Mendlewicz J; Lotstra F
    Psychiatry Res; 1995 Sep; 61(3):161-71. PubMed ID: 8545500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
    Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.
    Wolkin A; Jaeger J; Brodie JD; Wolf AP; Fowler J; Rotrosen J; Gomez-Mont F; Cancro R
    Am J Psychiatry; 1985 May; 142(5):564-71. PubMed ID: 3872603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional cerebral glucose metabolism in healthy volunteers determined by fluordeoxyglucose positron emission tomography: appearance and variance in the transaxial, coronal, and sagittal planes.
    Ivançević V; Alavi A; Souder E; Mozley PD; Gur RE; Bénard F; Munz DL
    Clin Nucl Med; 2000 Aug; 25(8):596-602. PubMed ID: 10944013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.
    Vollenweider FX; Leenders KL; Scharfetter C; Maguire P; Stadelmann O; Angst J
    Neuropsychopharmacology; 1997 May; 16(5):357-72. PubMed ID: 9109107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative glucose metabolic rate higher in white matter in patients with schizophrenia.
    Buchsbaum MS; Buchsbaum BR; Hazlett EA; Haznedar MM; Newmark R; Tang CY; Hof PR
    Am J Psychiatry; 2007 Jul; 164(7):1072-81. PubMed ID: 17606659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of decreased uptake of 18F-fluorodeoxyglucose in the cerebral cortex of patients with intracranial non-Hodgkin's lymphoma lesions through PET/CT.
    Zhang Q; Tian T; Wang L; Qiu H; Li D
    Biomed Pharmacother; 2016 Dec; 84():1331-1336. PubMed ID: 27810790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain metabolism in autism. Resting cerebral glucose utilization rates as measured with positron emission tomography.
    Rumsey JM; Duara R; Grady C; Rapoport JL; Margolin RA; Rapoport SI; Cutler NR
    Arch Gen Psychiatry; 1985 May; 42(5):448-55. PubMed ID: 3872650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.